Dublin-listed pharmaceutical services company Open Orphan has signed a new contract with a Japanese group which it expects will generate “significant revenue” for subsidiary Venn Life Sciences over the next year. Open

Dublin-listed Open Orphan has won a contract to conduct a trial into a vaccine for Covid-19. The deal is with Codagenix and 48 adults will volunteer for the clinical trial.

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has

Dublin-listed pharmaceutical services company Open Orphan has signed a new deal with New York-based Codagenix for the phase one trial of a new Covid-19 vaccine. The trial, which will evaluate the safety and ability

Dublin-listed pharmaceutical company Open Orphan has announced a new contract with Codagenix to conduct a first human trial evaluating safety and immunogenicity of a single-dose Covid-19 vaccine. hVIVO, part of

Open Orphan plc (LON:ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has

Research on vaccines against the novel coronavirus (SARS-CoV-2) is being carried out all over the world. If a vaccine becomes available in the future, the Ministry of Health, Welfare and

Dublin-listed Open Orphan has signed an option to buy CHIMagents for a nominal sum. CHIMagents was recently established to assist in the design, manufacture and testing of challenge agents which

Open Orphan plc (LON:ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is

Employers hoping to get more staff back to work by using coronavirus antibody tests have been warned that they could miss one in 10 cases of Covid-19. According to researchers